The pharmaceutical industry in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This effective medication, used to treat glucose intolerance, has gained remarkable attention from both patients and healthcare professionals. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the US